Supplementary Data from Large B-cell Lymphomas of Immune-Privileged Sites Relapse via Parallel Clonal Evolution from a Common Progenitor B CellG. Tjitske Los-de Vries(Amsterdam University Medical Centers), Margaretha G.M. RoemerUnknownMay 18, 202310.1158/0008-5472.22929963.v1Cited by 0SaveCiteExport RISWatch citationsRelated PapersEpcoritamab induces potent anti-tumor activity against malignant B-cells from patients with DLBCL, FL and MCL, irrespective of prior CD20 monoclonal antibody treatment|Blood Cancer Journal|2021|95Supplementary Data from Large B-cell Lymphomas of Immune-Privileged Sites Relapse via Parallel Clonal Evolution from a Common Progenitor B Cell|Unknown|2023|0Supplementary Data from Large B-cell Lymphomas of Immune-Privileged Sites Relapse via Parallel Clonal Evolution from a Common Progenitor B Cell|Unknown|2025|0